对芬太尼和西拉检测阳性的患者中的西拉药业动力学
Yanchun Lin1, Christopher W Farnsworth1, Vahid Azimi1
1Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, United States.
Clinical chemistry
|November 20, 2024
概括
作为芬太尼的一种 adulterant 的 xylazine 的人类半衰期大约为 12 小时. 它的代谢物,氧氨酸和硫氧氨酸,也可在血中检测到,告知效应的持续时间和检测窗口.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 药物新陈代谢 药物新陈代谢
背景情况:
- 克西拉越来越多地出现在非法药物供应中,通常与芬太尼混合.
- 这种组合会带来严重的健康风险,但对于西拉的人类药理动力学数据很少.
研究的目的:
- 为了确定在人类中西拉的药理动力学概况.
- 在人体血中识别和量化克西拉代谢物.
主要方法:
- 从28名使用LC-MS/MS的患者的连续血样本中量化克西拉.
- 通过产品离子扫描和多重反应监测来确定终端半衰期和克西拉代谢物的识别.
主要成果:
- 人类中西拉的终端半衰期中位数计算为12.0小时.
- 在所有克西拉阳性血样本中检测到氧克西拉和硫克西拉代谢物.
结论:
- 人类克西拉的半衰期比动物研究中报告的要长,延长了预期的效果持续时间和检测窗口.
- 克西拉的代谢物,氧克西拉和硫克西拉,在血中循环的持续时间与克西拉本身相似.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
84
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
84
Depolarizing Blockers: Pharmocokinetics
308
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
308
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
429
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
429
Nonlinear Pharmacokinetics: Overview
278
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
278
Opioid Analgesics: Synthetic and Semisynthetic Opioids
225
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
225
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
42
In pharmacokinetics, the elimination rate of a drug following a capacity-limited model is primarily controlled by two parameters: Vmax and KM. These parameters are crucial in how the drug behaves inside the body after administration.
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
42


